FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

372488002: Dolasetron (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1197781015 Dolasetron (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1211023010 Dolasetron en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolasetron Is a Substance with 5-hydroxytryptamine-3-receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Dolasetron Has disposition 5-hydroxytryptamine-3-receptor antagonist true Inferred relationship Existential restriction modifier
Dolasetron Is a Drug allergen false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dolasetron mesilate Is a False Dolasetron Inferred relationship Existential restriction modifier
Product containing dolasetron Has active ingredient True Dolasetron Inferred relationship Existential restriction modifier 1
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Dolasetron mesylate monohydr 50mg tablet Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Dolasetron mesylate monohydr 100mg/5 mL solution Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Product containing precisely dolasetron mesilate 50 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Product containing precisely dolasetron mesilate 200 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Dolasetron mesilate 20mg/mL injection solution 0.625mL vial Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Dolasetron mesilate 20mg/mL injection solution 5mL vial Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Product containing dolasetron in oral dose form (medicinal product form) Has active ingredient True Dolasetron Inferred relationship Existential restriction modifier 1
Product containing dolasetron in parenteral dose form (medicinal product form) Has active ingredient True Dolasetron Inferred relationship Existential restriction modifier 1
Dolasetron mesilate Is modification of True Dolasetron Inferred relationship Existential restriction modifier
Dolasetron Has active ingredient True Dolasetron Inferred relationship Existential restriction modifier 1
Product containing only dolasetron in oral dose form (medicinal product form) Has active ingredient True Dolasetron Inferred relationship Existential restriction modifier 1
Product containing only dolasetron in parenteral dose form (medicinal product form) Has active ingredient True Dolasetron Inferred relationship Existential restriction modifier 1
Product containing precisely dolasetron mesilate 200 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Product containing precisely dolasetron mesilate 50 milligram/1 each conventional release oral tablet (clinical drug) Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Anzemet 200mg tablets (Amdipharm) Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Dolasetron 50mg tablets 3 tablet Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Dolasetron 200mg tablets 3 tablet Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Dolasetron 200mg tablets 6 tablet Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Anzemet 50mg tablets (Amdipharm) 3 tablet Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Anzemet 200mg tablets (Amdipharm) 3 tablet Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Anzemet 200mg tablets (Amdipharm) 6 tablet 2 x 3 tablets Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Dolasetron 100mg/5ml solution for injection ampoules Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Dolasetron 12.5mg/0.625ml solution for injection ampoules Has active ingredient False Dolasetron Inferred relationship Existential restriction modifier
Anzemet I.V. 100mg/5ml solution for injection ampoules (Amdipharm) Has active ingredient True Dolasetron Inferred relationship Existential restriction modifier
Anzemet I.V. 12.5mg/0.625ml solution for injection ampoules (Amdipharm) Has active ingredient True Dolasetron Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start